Frontlight ResearchEarly access
Colorectal cancer trials in Italy
157 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleROMANCE: "Irinotecan Plus Cetuximab Rechallenge Versus Trifluridine/Tipiracil Plus Bevacizumab in Molecularly Selected Metastatic Colorectal Cancer"
- Where
- Alexandria, Ancona, Avellino, Aviano, Brescia, Caserta, Castellana Grotte, Catania, Catanzaro, Florence, Meldola, Milan, Milano, Mirabella Eclano, Modena, Naples, Padova, Palermo, Pavia, Pisa, Rome, Rozzano, San Giovanni Rotondo, Sassari, Statte, Tricase, Varese
- Age
- 18 years and over
- People
- 150
- Run by
- Gruppo Oncologico Italia Meridionale
See details and how to joinNCT07381764 · EU 2025-521319-38-00 - Phase 2Taking peopleA study to evaluate the safety and efficacy of two dose levels of ONO-4578 with Opdivo®, in combination with mFOLFOX6 and bevacizumab versus standard of care in participants with non MSI-H/dMMR, PD-L1 positive advanced colorectal cancer.
- Where
- Milan, Naples, Padova, Rozzano
- Age
- 18 years and over
- People
- 76 worldwide
- Run by
- Ono Pharmaceutical Co. Ltd.
See details and how to join2024-519590-19-00 - Phase 1Taking peopleA Phase 1/1b Study of IAM1363 in HER2 Cancers
- Where
- Florence, Milan, Naples
- Age
- 18 years and over
- People
- 383 worldwide
- Run by
- Iambic Therapeutics, Inc
See details and how to joinNCT06253871 - Phase 1Taking peoplePhase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
- Where
- Candiolo, Milan
- Age
- 12 years to 85 years
- People
- 411 worldwide
- Run by
- Inhibrx Biosciences, Inc
See details and how to joinNCT03715933 · EU 2023-508139-29-00 - Phase 2Not yet taking people in ItalyImmune dynamics and biomarkers of anti-tumor response in BMS-986340 (anti-CCR8) and nivolumab (anti-PD-1) co-treatment of metastatic tumors
- Where
- Rozzano
- Age
- 18 years and over
- People
- 30
- Run by
- Humanitas Mirasole S.p.A.
See details and how to join2025-524125-40-01 - Phase 3Taking peopleStudy of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation
- Where
- Brescia, Castellana Grotte, Florence, Foggia, Genova, Meldola (FC), Milan, Naples, Padova, Palermo, Pesaro, Pisa, Ravenna, Rozzano MI, San Giovanni Rotondo, Udine, Verona
- Age
- 18 years and over
- People
- 450 worldwide
- Run by
- Amgen
See details and how to joinNCT06252649 - No phaseNot yet taking people in ItalyImplementation Of A Telesurgery Program At A Referral Center For Robotic Surgery
- Where
- Roma, Rome
- Age
- 18 years and over
- People
- 25
- Run by
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
See details and how to joinNCT07792109 - Phase 1/2Taking peopleA Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
- Where
- Candiolo, Milan, Naples, Roma, Rozzano, Siena
- Age
- 18 years and over
- People
- 1,109 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT04895709 - No phaseTaking peopleMicrobiome Testing for the Screening of Colorectal Cancer
- Where
- Roma
- Age
- 50 years to 74 years
- People
- 1,006
- Run by
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
See details and how to joinNCT06588166 - No phaseTaking peopleMicrobiome-based Diagnostic Tool for the Screening of Colorectal Cancer (GUILTI)
- Where
- Rome
- Age
- 50 years to 74 years
- People
- 1,202
- Run by
- Catholic University of the Sacred Heart
See details and how to joinNCT06738173 - Phase 3Taking peopleSotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Subjects With Metastatic Colorectal Cancer With KRAS p.G12C Mutation (CodeBreaK 301)
- Where
- Brescia, Castellana Grotte, Florence, Foggia, Genoa, Meldola, Milan, Naples, Padova, Palermo, Pesaro, Pisa, Ravenna, Rome, Rozzano, San Giovanni Rotondo, Udine, Verona
- Age
- 18 years to 64 years
- People
- 241 worldwide
- Run by
- Amgen Inc.
See details and how to join2022-502352-31-00 - Phase 1Taking peopleAMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors
- Where
- Milan, Pisa, Verona
- Age
- 18 years and over
- People
- 434 worldwide
- Run by
- Amgen
See details and how to joinNCT07094113 - Phase 1Taking peoplePhase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
- Where
- Milan, Reggio Emilia
- Age
- 18 years to 100 years
- People
- 162 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06562192 - Phase 3Taking peopleA Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
- Where
- Avellino, Brescia, Cagliari, Catania, Florence, Foggia, Genoa, Milan, Naples, Orbassano, Padova, Pavia, Pisa, Reggio Emilia, Rome, Sondrio, Tricase, Verona
- Age
- 18 years and over
- People
- 400 worldwide
- Run by
- Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT05253651 · EU 2024-514180-25-00 - Phase 1Taking peopleA Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
- Where
- Milan, Rozzano, Verona
- Age
- 18 years and over
- People
- 710 worldwide
- Run by
- Incyte Corporation
See details and how to joinNCT06179160 · EU 2023-507091-47-00 - Phase 2Taking peopleRandomized Study to Evaluate Melphalan/HDS Treatment Followed by Trifluridine–tipiracil plus Bevacizumab Versus Trifluridine–tipiracil plus Bevacizumab Alone in Metastatic Colorectal Cancer Patients
- Where
- Milan
- Age
- 18 years and over
- People
- 35 worldwide
- Run by
- Delcath Systems Inc.
See details and how to join2024-520356-24-00 - No phaseTaking peopleCOLON ERDERLY LOW DOSE
- Where
- Genoa, Genova
- Age
- 70 years to 99 years
- People
- 51
- Run by
- Matteo Clavarezza
See details and how to joinNCT06840977 - Phase 2Taking peopleA Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®, in Combination With mFOLFOX6 and Bevacizumab Versus Standard of Care in Participants With Non-MSI-H/dMMR, PD-L1 Positive Advanced Colorectal Cancer
- Where
- Milan, Naples, Padova
- Age
- 18 years and over
- People
- 144 worldwide
- Run by
- Ono Pharmaceutical Co., Ltd.
See details and how to joinNCT06948448 - No phaseNot yet taking people in ItalySCARLET - Italian proSpeCtionAl obseRvationaL multicEntre Study on Treatment for recTal pT1 Cancer
- Where
- Roma
- Age
- 18 years and over
- People
- 196
- Run by
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
See details and how to joinNCT07695519 - No phaseTaking peopleEarly Onset Colorectal Cancer Detection
- Where
- Milan
- Age
- 18 years to 50 years
- People
- 400 worldwide
- Run by
- City of Hope Medical Center
See details and how to joinNCT06342401 - No phaseTaking peopleEarly Detection of Advanced Adenomas and Colorectal Cancer
- Where
- Milan
- Age
- 18 years and over
- People
- 2,000 worldwide
- Run by
- City of Hope Medical Center
See details and how to joinNCT06342440 - No phaseTaking peopleEfficacy and Safety of the CG-100 Intraluminal Bypass Device
- Where
- Milan
- Age
- 22 years to 70 years
- People
- 250 worldwide
- Run by
- Colospan Ltd.
See details and how to joinNCT04184973 - Phase 1/2Taking peopleA Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors
- Where
- Milan, Ravenna, Rossano, Siena
- Age
- 18 years and over
- People
- 180 worldwide
- Run by
- Alentis Therapeutics AG
See details and how to joinNCT07169734 · EU 2025-521441-24-00 - Phase 1Taking peopleTHE-0504 in Patients With Solid Tumors
- Where
- Rome
- Age
- 18 years and over
- People
- 30
- Run by
- Thena Biotech S.r.l.
See details and how to joinNCT07646106 · EU 2023-503787-17-00 - Phase 2Taking peopleWindow-of-opportunity umbrella platform trial of short-course pre-operative targeted treatments in patients with molecularly selected and resectable primary colorectal cancer: the UNICORN study.
- Where
- Aviano, Brescia, Candiolo, Cremona, Meldola, Milan, Modena, Naples, Padova, Pisa, Prato, Ravenna, Rome, Rozzano, Tricase, Udine
- Age
- 18 years and over
- People
- 112
- Run by
- Fondazione GONO G.I.
See details and how to join2022-501308-90-00